Phathom Pharmaceuticals Inc has a share price target of US$ 21, revenue growth forecast of 196.2%, and profit growth estimate of 8.9% for FY25, based on top 9 analyst calls.
Upgrade Your Plan
You need to upgrade your subscription plan to access this feature